A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
ModernaTX, Inc.
Akamis Bio
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc.
Abbott Molecular
Viralytics
Genelux Corporation
Merck Sharp & Dohme LLC
Akamis Bio
CG Oncology, Inc.
Novartis
Gilead Sciences
GlaxoSmithKline
AlloVir
GlaxoSmithKline
GlaxoSmithKline
Vaxart
Biotest Pharmaceuticals Corporation
Chiltern Pesquisa Clinica Ltda